Methadose (Propylene Glycol)

Propylene glycol works by acting as a miscible solvent that reduces viscosity and enhances the solubility of both water‑soluble and lipophilic compounds. This enables uniform distribution of the active drug within the dosage form and can aid in absorption across biological membranes.

Methadose is an excipient, not a therapeutic agent, so it does not have a prescribed dose. The amount used in a formulation is determined by the product developer or prescribing clinician based on the specific drug product requirements.

Limited clinical data are available for propylene glycol exposure during pregnancy and lactation. It is generally regarded as low risk at typical excipient levels, but clinicians should evaluate the benefit‑risk balance and consider alternative formulations if concerns exist.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with alternatives such as glycerol or polyethylene glycol, propylene glycol offers lower viscosity, excellent miscibility with water and many organic solvents, and a relatively favorable safety profile. Choice of excipient depends on formulation goals, target patient population and regulatory considerations.

Methadose should be stored at ambient temperature, preferably below 25 °C, in its original container. Protect it from moisture, direct sunlight and excessive heat to maintain its purity and prevent degradation.

Methadose is not administered directly to patients. It is incorporated into oral dosage forms during manufacturing, where it serves as a solvent or humectant within liquids, tablets, capsules or topical preparations.

Serious risks, although rare, include anaphylactic reactions, metabolic acidosis from accumulation of glycolic acid metabolites, and renal dysfunction in patients with compromised kidney function. Prompt medical attention is required if any of these symptoms arise.

Individuals with a documented hypersensitivity to propylene glycol, or those with severe renal impairment, should avoid products containing this excipient. Clinicians should assess patient history before selecting formulations that include propylene glycol.